Acquisition of 60,000 SF Biotech Flex Facility, Cambridge

Deal value: $31,200,000

Acquisition of a 60,000 SF biotech flex facility in Cambridge, MA, with 65% lab, 25% office, and 10% warehouse, targeting early-stage life science tenants.

The core motivation is to acquire a well-located, flexible biotech facility in Cambridge at a time of elevated lab vacancies and softened rents, positioning for a rebound in life sciences demand. The strategic purpose is to target early-stage life science tenants who now have more leasing options, betting on Cambridge’s enduring status as a global biotech hub and the eventual recovery of venture funding and tenant growth.